Search

The purpose of this risk assessment is to evaluate the risk to the citizens of Europe of CPE spread through patient mobility and to assess the effectiveness of infection control methods to stop the spread of CPE within healthcare institutions.

​Since 2011, cases of infection caused by Mycobacterium chimaera have been detected in patients having previously undergone cardiac surgery in Europe.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2015, and includes updates on influenza, Salmonella Enteritidis, polio, avian influenza, Ebola virus, Mycobacterium chimaera and MERS.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2015, and includes updates on Salmonella Enteritidis, influenza, Mycobacterium chimaera, Ebola virus, MERS, avian influenza and polio.

This rapid risk assessment provides several options to reduce the risk of CRE, e.g. treatment options, transmission prevention and measures related to the healthcare system.

This document assesses the risk for patients and healthcare systems in the EU/EEA due to the global mcr-1 plasmid-mediated gene epidemic.

In view of new evidence, ECDC has updated its rapid risk assessment on the potential risk of invasive cardiovascular infection by M. chimaera associated with the use of heater-cooler units.

This risk assessment provides an overview of the epidemiological situation in Europe and describes a number of response options.

​Due to its propensity to cause outbreaks and its antifungal resistance, C. auris poses a risk for patients in healthcare facilities in Europe. Difficulties with laboratory identification, combined with a lack of awareness of this new Candida species, might result in unnoticed outbreaks. There is a clear need to raise awareness in European healthcare facilities in order adapt laboratory testing strategies and implement enhanced control measures to prevent further hospital outbreaks.